Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Clarus to Market Perform

Raymond James Downgrades Clarus to Market Perform

Raymond James analyst Joseph Altobello downgrades Clarus (NASDAQ:CLAR) from Outperform to Market Perform.

byBenzinga Newsdesk

August 18, 2022

1 minute read

Raymond James analyst Joseph Altobello downgrades Clarus (NASDAQ:CLAR) from Outperform to Market Perform.

These Analysts Slash Their Forecasts On Phreesia Following Q2 Results

By Lisa Levin

September 7, 11:00 AM

Phreesia, Inc. (NYSE: PHR) reported a wider-than-expected second-quarter loss.

PHR

What’s Going On With AMD Stock Monday?

By Anusuya Lahiri

October 16, 1:52 PM

Advanced Micro Devices, Inc (NASDAQ: AMD) stock is trading higher Monday in line with the broader index Invesco QQQ Trust, Series 1 (NASDAQ: QQQ) despite reports of the U.S.

AMD

$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,700 Today

By Benzinga Insights

December 8, 4:02 PM

Pioneer Natural Resources (NYSE:PXD) has outperformed the market over the past 15 years by 4.15% on an annualized…

PXD

Reported Late Thursday, Vicarious Surgical Completes Public Demonstration Of Beta 2 Surgical Robotic System

By Benzinga Newsdesk

December 23, 2:07 AM

Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first

RBOT

Raymond James Downgrades Clarus to Market Perform

Related Posts

These Analysts Slash Their Forecasts On Phreesia Following Q2 Results

What’s Going On With AMD Stock Monday?

$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,700 Today

Reported Late Thursday, Vicarious Surgical Completes Public Demonstration Of Beta 2 Surgical Robotic System